{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:36:11Z","timestamp":1791941771818,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UQ CIEF"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["AP1063214"],"award-info":[{"award-number":["AP1063214"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["AI114671"],"award-info":[{"award-number":["AI114671"]}]},{"name":"NIH","award":["DE020607"],"award-info":[{"award-number":["DE020607"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejmech.2016.04.064","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T17:27:52Z","timestamp":1461950872000},"page":"353-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis"],"prefix":"10.1016","volume":"120","author":[{"given":"A.M.","family":"Jarrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Hansford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pelingon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6689-4236","authenticated-orcid":false,"given":"M.S.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-8363","authenticated-orcid":false,"given":"T.","family":"Karoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.T.","family":"Blaskovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.04.064_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","article-title":"Drug targets and mechanisms of resistance in the anaerobic protozoa","volume":"14","author":"Upcroft","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2016.04.064_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/8.2.228","article-title":"Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality","volume":"8","author":"Walsh","year":"1986","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2012.10.005","article-title":"Potential effects of global environmental changes on cryptosporidiosis and giardiasis transmission","volume":"29","author":"Lal","year":"2013","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2016.04.064_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.gtc.2006.03.006","article-title":"An updated teview on Cryptosporidium and Giardia","volume":"35","author":"Huang","year":"2006","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.ejmech.2016.04.064_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11894-007-0054-8","article-title":"Amebic colitis: new insights into pathogenesis and treatment","volume":"9","author":"Bercu","year":"2007","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.ejmech.2016.04.064_bib6","doi-asserted-by":"crossref","first-page":"e1002512","DOI":"10.1371\/journal.ppat.1002512","article-title":"Mechanisms of pathogenesis, infective dose and virulence in human parasites","volume":"8","author":"Leggett","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2016.04.064_bib7","unstructured":"Biodefense Category A, B, C Pathogens, Niaid.Nih.Gov. (n.d.). https:\/\/www.niaid.nih.gov\/topics\/biodefenserelated\/biodefense\/pages\/cata.aspx (accessed 04.01.16)."},{"key":"10.1016\/j.ejmech.2016.04.064_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/CMR.14.1.114-128.2001","article-title":"Treatment of giardiasis","volume":"14","author":"Gardner","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2016.04.064_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpgasthep0557","article-title":"Treatment options for the eradication of intestinal protozoa","volume":"3","author":"Farthing","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2016.04.064_bib10","series-title":"Product Information Fasigyn (Tinidazole)","author":"Pfizer Australia Pty Ltd","year":"2013"},{"key":"10.1016\/j.ejmech.2016.04.064_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000682","article-title":"A\u00a0Meta-analysis of the affectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis","volume":"4","author":"Solaymani-Mohammadi","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmi.2015.04.019","article-title":"Increased incidence of nitroimidazole-refractory giardiasis at the hospital for tropical diseases, London: 2008-2013","volume":"21","author":"Nabarro","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2016.04.064_bib13","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","article-title":"Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase","volume":"274","author":"Wassmann","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.04.064_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole\u2013 a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib15","doi-asserted-by":"crossref","first-page":"17564","DOI":"10.1073\/pnas.1302664110","article-title":"Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity","volume":"110","author":"Miyamoto","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2016.04.064_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2015.06.019","article-title":"Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites","volume":"101","author":"Jarrad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.04.064_bib17","unstructured":"D.R. Hoff, Nitroimidazole carboxamides, US patent 3715364, 1973."},{"key":"10.1016\/j.ejmech.2016.04.064_bib18","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1637\/7420-081005R.1","article-title":"Blackhead disease (Histomoniasis) in poultry: a critical review","volume":"49","author":"McDougald","year":"2005","journal-title":"Avian Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QCO.0000000000000128","article-title":"Trichomonas vaginalis origins, molecular pathobiology and clinical considerations","volume":"28","author":"Hirt","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0035-9203(92)90095-T","article-title":"Induction of metronidazole and furazolidone resistance in Giardia","volume":"86","author":"Townson","year":"1992","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2016.04.064_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0035-9203(88)90278-7","article-title":"Altered uptake of metronidazole in\u00a0vitro by stocks of Giardia intestinalis with different drug sensitivities","volume":"82","author":"Boreham","year":"1988","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2016.04.064_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0035-9203(78)90144-X","article-title":"A\u00a0new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba","volume":"72","author":"Diamond","year":"1978","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2016.04.064_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A\u00a0high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2016.04.064_bib24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.01675-12","article-title":"A\u00a0reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia","volume":"57","author":"Tejman-Yarden","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2016.04.064_bib25","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/AAC.01842-09","article-title":"Effects of inoculum, pH, and cations on the in\u00a0vitro activity of fidaxomicin (OPT-80, PAR-101) against Clostridium difficile","volume":"54","author":"Babakhani","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl.\u00a02","key":"10.1016\/j.ejmech.2016.04.064_bib26","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/cis453","article-title":"Fidaxomicin inhibits spore production in Clostridium difficile","volume":"55","author":"Babakhani","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2016.04.064_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":"Compilation of 222 drugs' plasma protein binding data and guidance for study designs","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2016.04.064_bib28","series-title":"Drug-like Properties: Concepts, Structure Design and Methods","first-page":"372","article-title":"Plasma protein binding methods","author":"Di","year":"2008"},{"key":"10.1016\/j.ejmech.2016.04.064_bib29","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/jm5016846","article-title":"Clostridium difficile drug pipeline: challenges in discovery and development of new agents","volume":"58","author":"Jarrad","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.04.064_bib30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2011.01.071","article-title":"1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis","volume":"46","author":"Trunz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.04.064_bib31","first-page":"165","article-title":"Mode of action of metronidazole on anaerobic bacteria and protozoa","volume":"93","author":"M\u00fcller","year":"1983","journal-title":"Surgery"},{"key":"10.1016\/j.ejmech.2016.04.064_bib32","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.biotechadv.2015.04.009","article-title":"Drug resistance in Giardia duodenalis","volume":"33","author":"Ansell","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2016.04.064_bib33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199223050-00002","article-title":"Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives","volume":"23","author":"Lau","year":"1992","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2016.04.064_bib34","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/0006-2952(78)90084-9","article-title":"Biliary and renal excretion, hepatic metabolism, and hepatic subcellular distribution of metronidazole in the rat","volume":"27","author":"LaRusso","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.04.064_bib35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials","volume":"36","author":"Lamp","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2016.04.064_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2885.2009.01119.x","article-title":"The pharmacokinetics of nitazoxanide active metabolite (tizoxanide) in goats and its protein binding ability in\u00a0vitro","volume":"33","author":"Zhao","year":"2010","journal-title":"J.\u00a0Vet. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2016.04.064_bib37","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in\u00a0vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.04.064_bib38","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: a new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.04.064_bib39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.14573\/altex.2009.3.214","article-title":"Comparison of metabolic stability and metabolite identification of 55 ECVAM\/ICCVAM validation compounds between human and rat liver homogenates and microsomes - a preliminary analysis","volume":"26","author":"Pelkonen","year":"2009","journal-title":"Altex"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416303579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416303579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:43:50Z","timestamp":1759326230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416303579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"alternative-id":["S0223523416303579"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.04.064","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726385579.793524155","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.04.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}